Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

Title
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Authors
Keywords
NAMI-A, Ruthenium, Phase I, Phase II, Clinical study, Gemcitabine, Non-small cell lung cancer
Journal
INVESTIGATIONAL NEW DRUGS
Volume 33, Issue 1, Pages 201-214
Publisher
Springer Nature
Online
2014-10-24
DOI
10.1007/s10637-014-0179-1

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started